Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Perspectives on Gene Therapy: Choroideremia Represents a Challenging Model for the Treatment of Other Inherited Retinal Degenerations

Translational Vision Science & Technology(2020)10.1167/tvst.9.3.17Source: DataRank Database

Perspectives on Gene Therapy: Choroideremia Represents a Challenging Model for the Treatment of Other Inherited Retinal Degenerations is a research paper published in Translational Vision Science & Technology (2020). On theSindex it has a DataRank of 0.457. It has been cited 20 times.

N/A

0.457DataRank · unranked

Scored on demand from live citation data

Open Access20 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (19 grants)OA: goldTopics (50)IDs (PubMed, PMC)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 100%Citation Network 0%

Base Score Contribution

0.457

From this paper's citation signal

Citation Network Contribution

Citation network not refreshed for this result

This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.

Learn more about DataRank methodology →

Authors (6)

Christopher Moen,Jacque L. Duncan ORCID,Stephen H. Tsang ORCID,Jasmina Cehajic‐Kapetanovic ORCID,Tomás S. Alemán ORCID

Live enrichment

PubMed:32714643 PMC:PMC7351877

NIA NIH HHS

Grant: R21 AG050437

NEI NIH HHS

Grant: U01 EY030580

NEI NIH HHS

Grant: R01 EY024698

NCI NIH HHS

Grant: P30 CA013696

Medical Research Council

Grant: G1000268

NEI NIH HHS

Grant: P30 EY019007

NEI NIH HHS

Grant: R01 EY018213

NEI NIH HHS

Grant: R01 EY026682

NEI NIH HHS

Grant: R24 EY027285

National Institutes of Health

Grant: 5R21AG050437-02

Evaluating GWAS AMD Candidate Loci by Gene Editing in Human iPS Cells

National Institutes of Health

Grant: 3P30CA013696-21S1

CANCER CENTER CORE SUPPORT GRANT

National Institutes of Health

Grant: 5U01EY030580-02

Precision genome surgery in autologous stem cell transplant

National Institutes of Health

Grant: 2P30EY019007-06A1

Core Facilities for Vision Research

National Institutes of Health

Grant: 5R01EY026682-04

Mechanistic Studies on Regenerative Medicine Approaches to Childhood Blindness

National Institutes of Health

Grant: 2R01EY018213-06A1

Defining Barriers to Gene Therapy

Canadian Institutes of Health Research

Grant: unidentified

unidentified

National Institutes of Health

Grant: 1R24EY027285-01A1

Translational Gene Therapy for CNGB1 Retinitis Pigmentosa

National Institutes of Health

Grant: 5R01EY024698-10

Gene Editing and Silencing in Phototransduction

National Institutes of Health

Grant: 5P30EY002162-34

P30 - CORE GRANT FOR VISION RESEARCH

goldLicense: cc-by-nc-nd

publisherhttps://watermark.silverchair.com/i2164-2591-231-1-1919.pdf?token=AQECAHi208BE49Ooan9kkhW_Ercy7Dm3ZL_9Cf3qfKAc485ysgAAAjwwggI4BgkqhkiG9w0BBwagggIpMIICJQIBADCCAh4GCSqGSIb3DQEHATAeBglghkgBZQMEAS4wEQQMS6ORhSEtx9Pkl6aoAgEQgIIB73ZHCbsKNUKw3CtzSLkDRSfK0ZOjEOiNCGbuFkul7VEcIb3uHuGc6E9RCNkwPKMkvFOGoHsa-SiZ7xkkIxo8q6woQvajgxECrNqUMO2rewGjNd9De5vMT-X7kvFYFfZJYY4T10-GjLXz6jHc0burhmNWzEIedvyfjCii6bVk3vh8xDn-UuJGzvZAZPtURKj95cE8SyJSNMnliBHTRNc0M0gs4NIN87y5IY-06Kg7THsEXUkvrvaZaUvz68eqZKgkLHcyJbHdMdoSxN0nTXxqERAIJvoFhcCDGOaaGtmKZ1eKqzVn48Dtd1rPZXs-BuEjGqJ7BsY4kDA8IfK8rSMpht8_OX5sEjUSb3l2MAvfcCSasi-X09jgZAEUYA8NzZJKZokd_JFv5sUHJ0P5_TZ5Cp5v9uVDDskDBgHJg-1TKaVhusbqMniRXvSgaJUuzmuLnXtDOU2m2rZjkP8vZG1yzaNaIj0tQozJxPXDAc9tnMLZQ1PlHBh876HtY4IcHy24_flHSuk8L45teMEqaaH7ZbvK4B8FIeLCcSJvxM-Po5qheMEQyTeTzV_Zz8Iiw-biYNSpR5p7bTO61Gm_K968d_iZX0zSiWngPyaD4oS5rxaURYbfayUij7GOaRN644VCEyb5-OFnmCigaQ2MrmVV-A

publisherhttps://tvst.arvojournals.org/article.aspx?articleid=2761571

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/7351877

Europe_PMChttps://europepmc.org/articles/PMC7351877

Europe_PMChttps://europepmc.org/articles/PMC7351877?pdf=render

Fields of Study

03 medical and health sciences0302 clinical medicine

MeSH Terms

HumansChoroideremiaRetinal DegenerationCanadaLeber Congenital AmaurosisGenetic Therapy

Keywords

Gene therapyRetinal degenerationChoroideremia1113 Opthalmology and Optometry (for)CanadaGenetic Therapy (mesh)Medical BiotechnologyLeber Congenital AmaurosisBiomedical Engineering610Canada (mesh)NeurodegenerativeBiotechnology (rcdc)EyeEye Disease and Disorders of Vision (rcdc)3212 Ophthalmology and Optometry (for-2020)Rare Diseases (rcdc)Eye (hrcs-hc)Rare Diseases0903 Biomedical Engineering (for)Opthalmology and Optometry3206 Medical Biotechnology (for-2020)GeneticsHumans32 Biomedical and Clinical Sciences (for-2020)Eye Disease and Disorders of VisionNeurosciences (rcdc)Ophthalmology and OptometryNeurodegenerative (rcdc)Humans (mesh)Biomedical and Clinical Sciences5.2 Cellular and gene therapiesGenetics (rcdc)Retinal Degeneration (mesh)Neurosciences5.2 Cellular and gene therapies (hrcs-rac)Genetic TherapyGene Therapy (rcdc)Choroideremia (mesh)Leber Congenital Amaurosis (mesh)PerspectiveBiotechnology

Sustainable Development Goals

SDG 3: 3. Good health